Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-30T16:19:29.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Publications section now states that publications are automatically filled from PubMed and displays revision: v3.3.1. The previous PubMed-origin wording and the older revision (v3.2.0) have been removed.
    Difference
    0.1%
    Check dated 2025-11-23T14:53:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The site-wide government funding status notice has been removed. This administrative change does not affect the study details, eligibility criteria, or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-16T14:31:53.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Results for NCT03222856 have been posted, including efficacy and safety outcomes. The study record now shows updated completion and enrollment dates.
    Difference
    0.4%
    Check dated 2025-11-02T00:52:47.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a prominent operating-status notice and links; v3.1.0 is removed.
    Difference
    2%
    Check dated 2025-10-04T12:33:13.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Update versioning from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-27T08:19:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.